23 results
P
stroke patients
I/C
intravenous thrombolysis (IVT), normal weight, non-obesity, non-overweight
O
3-mo poor functional outcome, 3-mo mortality
P
lung disease, li, ipf
I/C
baicalin, no intervention
O
reduced inflammation, decreased apoptosis, protected against progression
P
patients with liver lesions
I/C
LI-RADS algorithm, original studies reporting probability of LR-M for HCC and non-HCC malignancy on MRI
O
pooled percentages of HCC and non-HCC malignancy for LR-M, sources of heterogeneity between reported results
P
Li QL, Yao MF, Cao RY, Zhao K, Wang XD
I/C
short dental implants, splinted and nonsplinted prostheses
O
survival rates
P
abiraterone, enzalutamide, apalutamide, docetaxel
I/C
combination therapy, hormonal treatments, chemotherapy, abiraterone vs. docetaxel, enzalutamide vs. docetaxel
O
overall survival (OS), median OS duration
P
children and young adults with HIV infection
I/C
vitamin D supplementation, placebo
O
serum 25(OH)D concentration, total BMD
P
Individuals participating in blood flow restriction (BFR) training
I/C
BFR training, High-intensity resistance training (HIRT)
O
Muscular strength, hypertrophy, and endurance
P
morbidly obese patients with heart failure with reduced ejection fraction
I/C
bariatric surgery
O
ejection fraction, New York Heart Association functional class
P
Black, Asian, Mixed and Other
I/C
COVID-19 infection, White ethnic group
O
mortality, intensive care unit (ICU) admission, invasive mechanical ventilation (IMV)
P
patients with obesity
I/C
bariatric surgery, no intervention
O
reduction in CIMT, increase in FMD, and increase in NMD markers